Trump, EU reach trade deal framework
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
27 minutes ago
- Toronto Star
Premiers Smith, Moe disappointed by Trump's tariffs but most exports remain duty-free
REGINA - The premiers of Alberta and Saskatchewan say they're disappointed by higher tariffs from U.S. President Donald Trump but pleased the majority of their exports won't face duties. Saskatchewan Premier Scott Moe says the Canada-United States-Mexico trade agreement remains in place, allowing 95 per cent of his province's exports to move into the United States tariff-free.
CTV News
27 minutes ago
- CTV News
Canada should refrain from any retaliatory measures: Sask. Premier Moe on U.S. tariffs hike
Premier of Saskatchewan Scott Moe speaks to media following the First Minister's Meeting in Saskatoon, Sask., Monday, June 2, 2025. THE CANADIAN PRESS/Liam Richards Saskatchewan Premier Scott Moe says U.S. President Donald Trump's new 35 per cent tariffs are disappointing and that Canada should refrain from any retaliatory measures that would cause harm to Canada's economy. However, he says that efforts remain in effect to ensure the Canada-U.S.-Mexico trade agreement (CUSMA) remains in effect. 'While Saskatchewan is disappointed in the Trump administration's decision to increase tariffs on non-CUSMA compliant Canadian goods to 35 per cent, Canada's efforts to ensure CUSMA remains in effect means that 95 per cent of Saskatchewan exports to the U.S. will remain tariff-free,' he said in a statement. Moe says CUSMA remaining in effect is very significant given the U.S. has imposed across-the-board tariffs on many countries. Trump signed an executive order activating tariffs against 68 countries and the European Union Thursday evening. New tariffs of 35 per cent on Canadian exports, effective Friday, exclude products under CUSMA, the White House has said. Moe says Canadian exports that remain tariff-free now have a competitive advantage relative to other countries facing tariffs on the same products. 'Our government will continue to engage with U.S. businesses and lawmakers to improve our trade relationship while continuing to expand our export markets to over 160 countries around the world that buy Saskatchewan products,' he said. He says Saskatchewan will also continue to press the federal government to adopt the 'Strong Saskatchewan, Strong Canada Plan' to approve economic infrastructure projects and eliminate regulations hindering economic development. Moe is expected to speak to reporters on Friday at 12 p.m., which can be livestreamed at the top of this article. -More to come…
Globe and Mail
27 minutes ago
- Globe and Mail
Unlocking ROI in Medical Imaging: The Strategic Growth of the Global MRI Systems Market
"The key players profiled in the MRI systems market are Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), Canon Inc. (Japan), Fonar Corporation (US)" Browse 226 market data Tables and 56 Figures spread through 259 Pages and in-depth TOC on "MRI Systems Market by Architecture (Open, Closed), Field Strength (High Field MRI Systems & Low Field MRI Systems), Design (Portable MRI Systems, Fixed/Stationary MRI Systems), End User (Hospitals, Diagnostic Clinic), Region - Global Forecast to 2030 Why MRI Systems Are a Smart Long-Term Investment As the healthcare industry undergoes a paradigm shift toward precision medicine and value-based care, Magnetic Resonance Imaging (MRI) has emerged as a cornerstone of diagnostic excellence. Forecasted to grow from USD 6.15 billion in 2024 to USD 9.01 billion by 2030, the MRI systems market offers robust opportunities for healthcare providers, OEMs, and strategic investors alike. For C-level executives, the MRI market represents more than just imaging hardware—it's a long-term investment in AI-enabled diagnostics, faster clinical workflows, and improved patient outcomes. With a CAGR of 6.5%, the sector is primed for innovation-led expansion and solid ROI. Market Snapshot: A Growing Industry with Predictable ROI 2024 Market Size: USD 6.15 Billion 2025 Projection: USD 6.56 Billion 2030 Forecast: USD 9.01 Billion CAGR: 6.5% (2024–2030) Driving Forces: Rise in neurological and musculoskeletal conditions Global aging population Increasing oncology imaging requirements Advancements in ultra-high-field MRI Favorable regulatory and reimbursement environments High-Value Applications: Brain & Neurological MRI Lead the Charge According to market research, brain and neurological MRI is the largest and fastest-growing application segment. This growth is driven by the surge in neurodegenerative disorders such as Alzheimer's, Parkinson's, epilepsy, and stroke. For hospital executives and diagnostic center owners, investing in neuro-MRI systems ensures better diagnostic precision, faster patient throughput, and enhanced clinical reputation—all critical ROI levers. Key ROI Insights: Faster diagnosis → Reduced inpatient days High diagnostic accuracy → Lower misdiagnosis risk Software upgrades → Extended equipment lifecycle Field Strength Matters: Ultra-High-Field MRI Is the Future The market is categorized by field strength: Low-to-mid-field High & very-high-field Ultra-high-field Among these, ultra-high-field MRI is experiencing the highest CAGR. These systems offer: Superior Signal-to-Noise Ratio (SNR) Enhanced contrast resolution Exceptional neuro and cardiovascular imaging As hospitals seek competitive clinical differentiation, ultra-high-field MRI investments will become a strategic priority. End User Analysis: Why Hospitals Dominate the Market Hospitals are currently the largest adopters of MRI systems and are expected to continue dominating. Their edge lies in: Access to capital investment budgets Integrated multi-specialty diagnostic care Alignment with value-based reimbursement models For CFOs and CIOs, the integration of MRI into enterprise imaging architecture ensures: Optimized resource allocation Predictable revenue from advanced imaging Better data utilization for AI algorithms Geographical Insights: North America Sets the Pace North America leads the global MRI systems market due to: Cutting-edge healthcare infrastructure Strong presence of OEMs and distributors Favorable regulatory and R&D support Healthcare providers in the U.S. are focusing on: High-throughput MRI centers Remote scanning capabilities Integration with AI and cloud-based radiology tools For OEMs and med-tech investors, the region is ripe for partnerships, pilot programs, and acquisitions. Request Sample Pages : Top Companies to Watch: Strategic Moves from Market Leaders 1. Siemens Healthineers (Germany) A frontrunner with a global manufacturing and R&D footprint, Siemens has deep investments in molecular imaging, AI-driven diagnostics, and portable MRI innovations. 2. GE HealthCare (US) GE's strategic growth is powered by inorganic acquisitions and global reach. Their solutions span molecular imaging, cardiac MRI, and biopharma integration. 3. Philips (Netherlands) Philips focuses on image-guided therapy, ultrasound integration, and cloud-connected platforms. Their Diagnosis & Treatment segment is a growth engine for MRI innovation. Other notable players: Canon Inc. (Japan) FUJIFILM Corporation (Japan) Fonar Corporation (US) Esaote S.p.A (Italy) United Imaging Healthcare (China) Innovation Trends: The Future of MRI is AI, Portability & Cloud Emerging innovation themes include: AI-enhanced image reconstruction Low-helium or helium-free systems Cloud-integrated radiology reporting Portable and point-of-care MRI Strategic Implications for C-suite: AI & ML tools embedded into MRI workflows can increase operational efficiency by 20–30% Cloud PACS integration ensures interoperability across multisite locations Portability introduces new revenue streams in mobile diagnostics and remote care What This Means for Healthcare Decision-Makers For CIOs, CFOs, and Clinical Executives, investing in MRI systems is no longer about hardware—it's a holistic ecosystem decision involving software, analytics, AI, and patient experience. Key Questions Executives Are Asking: How does MRI investment impact long-term patient retention and referral growth? Can we bundle MRI services with AI diagnostics for higher margins? What's the total cost of ownership (TCO) versus projected operational ROI? Conclusion: MRI Systems as a Strategic Differentiator in 2030 As demand for advanced diagnostic capabilities surges globally, MRI systems stand out as a high-impact, high-yield investment. With expanding clinical applications, regulatory support, and innovation momentum, this is an opportunity that healthcare leaders cannot afford to overlook. Whether you're managing hospital procurement, evaluating M&A options in the imaging space, or scaling a diagnostic chain, the MRI systems market offers sustainable ROI, technological resilience, and significant growth potential through 2030. For more information, Inquire Now!
